You are currently viewing a new version of our website. To view the old version click .

1,196 Results Found

  • Review
  • Open Access
34 Citations
11,892 Views
28 Pages

Systems Thinking Accident Analysis Models: A Systematic Review for Sustainable Safety Management

  • Mahdieh Delikhoon,
  • Esmaeil Zarei,
  • Osiris Valdez Banda,
  • Mohammad Faridan and
  • Ehsanollah Habibi

12 May 2022

Accident models are mental models that make it possible to understand the causality of adverse events. This research was conducted based on five major objectives: (i) to systematically review the relevant literature about AcciMap, STAMP, and FRAM mod...

  • Article
  • Open Access
822 Views
13 Pages

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3–5 Months

  • Liwei Shi,
  • Zhe Zhang,
  • Yuqing Liu,
  • Maoguang Li,
  • Weicai Lu,
  • Yue Yang,
  • Dan Zhao,
  • Bin Wang and
  • Wenjian Fang

30 September 2025

Background/Objectives: This study aimed to evaluate the immunogenicity and safety of a Meningococcal A and C Polysaccharide Conjugate Vaccine in 3–5-month-old infants. A single-center, randomized, blinded, positive-controlled phase III clinical...

  • Article
  • Open Access
2 Citations
3,845 Views
14 Pages

Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Esteban Jódar-Gimeno,
  • Jose Luis Pérez-Castrillón,
  • Ján Nociar,
  • Michal Lojka,
  • Dimitar Nikolov,
  • Fernando Cereto-Castro,
  • Snežana Novković,
  • Umberto Tarantino,
  • Nadia Mehsen-Cetre and
  • Paula Arranz
  • + 3 authors

5 November 2024

Background/Objective: Optimal vitamin D levels are required for bone health and proper functionality of the nervous, musculoskeletal and immune systems. The objective of this study was to assess the efficacy and safety profiles of new weekly calcifed...

  • Article
  • Open Access
2 Citations
3,216 Views
18 Pages

The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial

  • Lili Huang,
  • Guangfu Li,
  • Yuhui Zhang,
  • Xue Zhao,
  • Kai Wang,
  • Chunyu Jia,
  • Wei Zhang,
  • Jiebing Tan,
  • Xiaofen Chen and
  • Qin Li
  • + 7 authors

26 April 2025

Background: Influenza is a serious contagious disease caused by influenza virus. It is particularly dangerous for children, potentially leading to severe and even fatal complications. The aim of this study was to evaluate the safety and immunogenicit...

  • Article
  • Open Access
72 Citations
11,477 Views
14 Pages

Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis

  • Haoyue Cheng,
  • Zhicheng Peng,
  • Wenliang Luo,
  • Shuting Si,
  • Minjia Mo,
  • Haibo Zhou,
  • Xing Xin,
  • Hui Liu and
  • Yunxian Yu

Nowadays, the vaccination with COVID-19 vaccines is being promoted worldwide, professionals and common people are very concerned about the efficacy and safety of COVID-19 vaccines. No published systematic review and meta-analysis has assessed the eff...

  • Article
  • Open Access
1,929 Views
20 Pages

Enhancing Patient Safety Education: Cross-Cultural Validation of the APSQ-III in Brazilian Healthcare Students

  • João Daniel de Souza Menezes,
  • Matheus Querino da Silva,
  • Emerson Roberto dos Santos,
  • Rodrigo Soares Ribeiro,
  • Natália Almeida de Arnaldo Silva Rodriguez Castro,
  • Isabela Amaral de Almeida Bistafa,
  • Alex Bertolazzo Quitério,
  • Eliana Fazuoli Chubaci,
  • Sônia Maria Maciel Lopes and
  • Flávia Cristina Custódio
  • + 11 authors

23 January 2025

Background: This study aimed to adapt and validate the Attitudes to Patient Safety Questionnaire (APSQ-III) for Brazilian Portuguese and to compare patient safety attitudes between medical and nursing students. Given the critical role of assessing sa...

  • Article
  • Open Access
14 Citations
4,192 Views
19 Pages

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

  • Alexander B. Ryzhikov,
  • Evgeny A. Ryzhikov,
  • Marina P. Bogryantseva,
  • Svetlana V. Usova,
  • Elena A. Nechaeva,
  • Elena D. Danilenko,
  • Stepan A. Pyankov,
  • Andrey S. Gudymo,
  • Anastasiya A. Moiseeva and
  • Galina S. Onkhonova
  • + 17 authors

The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthe...

  • Article
  • Open Access
16 Citations
3,539 Views
9 Pages

The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial

  • Sheikh Mohammad Fazle Akbar,
  • Mamun Al Mahtab,
  • Julio Cesar Aguilar,
  • Osamu Yoshida,
  • Sakirul Khan,
  • Eduardo Penton,
  • Guillen Nieto Gerardo and
  • Yoichi Hiasa

30 December 2021

The objective of the present study was to assess the safety and efficacy of a therapeutic vaccine containing both HBsAg and HBcAg (NASVAC) in patients with chronic hepatitis B (CHB) three years after the end of treatment (EOT) as a follow-up of a pha...

  • Article
  • Open Access
29 Citations
3,081 Views
26 Pages

Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity

  • Marialuisa Piccolo,
  • Maria Grazia Ferraro,
  • Federica Raucci,
  • Claudia Riccardi,
  • Anella Saviano,
  • Irene Russo Krauss,
  • Marco Trifuoggi,
  • Michele Caraglia,
  • Luigi Paduano and
  • Daniela Montesarchio
  • + 4 authors

14 October 2021

Selectivity and efficacy towards target cancer cells, as well as biocompatibility, are current challenges of advanced chemotherapy powering the discovery of unconventional metal-based drugs and the search for novel therapeutic approaches. Among secon...

  • Article
  • Open Access
2 Citations
5,341 Views
13 Pages

31 May 2024

Background: Fexuprazan (Fexuclue®; Daewoong Pharmaceutical Co., Ltd., Seoul, Korea) is a novel potassium-competitive acid blocker (P-CAB). This multi-center, randomized, double-blind, active-controlled, parallel-group, therapeutic confirmatory, phase...

  • Article
  • Open Access
4 Citations
4,238 Views
20 Pages

This study considers an asset-liability optimization model based on constraint robustness with the chance constraint of capital to risk assets ratio in a safety-first framework under the condition that only moment information is known. This paper aim...

  • Article
  • Open Access
39 Citations
9,376 Views
19 Pages

12 June 2020

This research aims to investigate how the adoption of King III can affect the corporate governance model of a sample of South African listed companies on the Johannesburg Stock Exchange (JSE). Particularly, we analyzed the influence of sustainability...

  • Article
  • Open Access
1,439 Views
13 Pages

Safety and Immunogenicity of Single-Dose of Adsorbed Tetanus Vaccine in Adults Aged 18–44 Years: Randomized, Double-Blind, Positive-Controlled Phase I/III Clinical Trial

  • Zhiqiang Xie,
  • Liyong Yuan,
  • Yaping Qiao,
  • Wangyang You,
  • Yurong Li,
  • Taotao Zhu,
  • Wei Zhang,
  • Lili Huang,
  • Jiebing Tan and
  • Xiaocan Jia
  • + 4 authors

13 September 2025

Background: The persistence of non-neonatal tetanus (non-NT) highlights the necessity of adult booster vaccines and post-traumatic prophylaxis. This Phase I/III clinical trial aimed to evaluate the safety and immunogenicity of a new adsorbed tetanus...

  • Article
  • Open Access
4 Citations
6,699 Views
9 Pages

Background: Capecitabine and oxaliplatin (CAPOX) and infusional 5-fluouracil, folinic acid, and oxaliplatin (FOLFOX) are the two chemotherapy regimens in current clinical use for the adjuvant treatment of colorectal cancer (CRC). Many centers in Newf...

  • Article
  • Open Access
7 Citations
3,072 Views
15 Pages

Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy

  • Ye He,
  • Hong Tian,
  • Chang Dai,
  • Rong Wen,
  • Xiaorong Li,
  • Keith A. Webster and
  • Wei Li

29 December 2021

The retinopathy of prematurity (ROP), a neovascular retinal disorder presenting in premature infants, is the leading causes of blindness in children. Currently, there is no approved drug therapy for ROP in the U.S., highlighting the urgent unmet clin...

  • Article
  • Open Access
5 Citations
2,856 Views
10 Pages

Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial

  • Yan Zheng,
  • Zhifang Ying,
  • Yanxiang Zou,
  • Taotao Zhu,
  • Dinggu Qian,
  • Weixiao Han,
  • Ya Jiang,
  • Zhiwei Jiang,
  • Xingyan Li and
  • Jianfeng Wang
  • + 5 authors

8 February 2022

Background: The Sabin-strain-based inactivated poliovirus vaccine (sIPV) plays an important role in poliomyelitis eradication in developing countries. As part of the phase III clinical development program, this study aimed to evaluate the safety, imm...

  • Systematic Review
  • Open Access
20 Citations
5,879 Views
21 Pages

20 September 2023

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6is) have transformed the treatment of hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) breast cancer over the last decade. These inhibitors are curre...

  • Retraction
  • Open Access
1,392 Views
1 Page

25 October 2024

The Journal of Clinical Medicine retracts the article entitled “A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis” [...]

  • Article
  • Open Access
339 Views
12 Pages

The Safety and Immunogenicity of a 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) in 12–23-Month Children: A Double-Blind, Randomized, Phase III Trial in China

  • Zhiqiang Xie,
  • Feiyu Wang,
  • Lili Huang,
  • Haitao Huang,
  • Guangwei Feng,
  • Xue Wang,
  • Jiebing Tan,
  • Xiaomin Ma,
  • Wangyang You and
  • Xiaolong Li
  • + 2 authors

24 November 2025

Objectives: This study systematically assessed the safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine (CRM197/TT, PCV13i) against the licensed PCV13 vaccine in a cohort of Chinese children between 12 and 23 months of age. Met...

  • Article
  • Open Access
1 Citations
2,826 Views
12 Pages

21 February 2025

Background/Objectives: Acute upper respiratory tract infections (URTIs) are common illnesses that cause significant discomfort due to symptoms such as fever, headache, sore throat, and muscle pain. Non-steroidal anti-inflammatory drugs (NSAIDs) are w...

  • Article
  • Open Access
1 Citations
4,487 Views
14 Pages

A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency

  • Jose Luis Pérez-Castrillón,
  • Esteban Jódar-Gimeno,
  • Ján Nociar,
  • Michal Lojka,
  • Dimitar Nikolov,
  • Fernando Cereto-Castro,
  • Snežana Novković,
  • Umberto Tarantino,
  • Nadia Mehsen-Cetre and
  • Paula Arranz
  • + 3 authors

13 February 2025

Background/Objectives: Given the crucial health benefits of vitamin D, addressing severe deficiencies is a pressing medical concern. This study aimed to evaluate the effectiveness and safety of two new weekly doses of calcifediol (100 µg and 12...

  • Brief Report
  • Open Access
1 Citations
2,096 Views
8 Pages

6 July 2024

Background: Phosphorylcholine has emerged as a potential adjunctive agent in cardiopulmonary bypass (CPB) circuits. Phosphorylcholine serves as a coating for the CPB circuit, potentially enhancing biocompatibility and reducing thrombotic events. Howe...

  • Article
  • Open Access
1,653 Views
11 Pages

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial

  • Nancy Nazaire-Bermal,
  • Ningning Jia,
  • Maria Angela C. Maronilla,
  • Josemaria F. Lopez,
  • Gang Zeng,
  • Wenbin Wu,
  • Adrielle Bernice C. Nimo,
  • Chunfang Luan and
  • Qianqian Xin

13 September 2025

Objectives: The varicella vaccine (VarV) produced by Sinovac (Dalian) obtained World Health Organization (WHO) prequalification in November 2022. However, no direct comparative studies have been conducted between VarV and other WHO-prequalified varic...

  • Article
  • Open Access
8,561 Views
13 Pages

23 May 2025

Objectives: This study aims to evaluate the efficacy and safety of oral supplementation with hydrolyzed collagen peptides (HCP) type I and type III (CollaSel PRO®) in reducing joint pain and stiffness and improving physical function in patients w...

  • Review
  • Open Access
17 Citations
4,398 Views
39 Pages

Innovative Photonic Sensors for Safety and Security, Part III: Environment, Agriculture and Soil Monitoring

  • Giovanni Breglio,
  • Romeo Bernini,
  • Gaia Maria Berruti,
  • Francesco Antonio Bruno,
  • Salvatore Buontempo,
  • Stefania Campopiano,
  • Ester Catalano,
  • Marco Consales,
  • Agnese Coscetta and
  • Antonello Cutolo
  • + 21 authors

16 March 2023

In order to complete this set of three companion papers, in this last, we focus our attention on environmental monitoring by taking advantage of photonic technologies. After reporting on some configurations useful for high precision agriculture, we e...

  • Article
  • Open Access
7,077 Views
11 Pages

23 March 2025

MBA-P01 is a newly developed botulinum toxin A (BoNT-A) product designed to provide similar clinical effects as OnabotulinumtoxinA (ONA-BoNT-A), thereby providing an alternative treatment option for glabellar lines. It is another holotoxin preparatio...

  • Article
  • Open Access
15 Citations
4,795 Views
22 Pages

NanoSafe III: A User Friendly Safety Management System for Nanomaterials in Laboratories and Small Facilities

  • Elina Buitrago,
  • Anna Maria Novello,
  • Alke Fink,
  • Michael Riediker,
  • Barbara Rothen-Rutishauser and
  • Thierry Meyer

19 October 2021

Research in nanoscience continues to bring forward a steady stream of new nanomaterials and processes that are being developed and marketed. While scientific committees and expert groups deal with the harmonization of terminology and legal challenges...

  • Article
  • Open Access
44 Citations
4,507 Views
12 Pages

MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results

  • Aurelie Garant,
  • Carol-Ann Vasilevsky,
  • Marylise Boutros,
  • Farzin Khosrow-Khavar,
  • Petr Kavan,
  • Hugo Diec,
  • Sylvain Des Groseilliers,
  • Julio Faria,
  • Emery Ferland and
  • Vincent Pelsser
  • + 3 authors

28 July 2022

Background: We explored image-guided adaptive endorectal brachytherapy patients electing non-operative management for rectal cancer. We present the first pre-planned interim analysis. Methods: In this open-label phase II–III randomized study, p...

  • Article
  • Open Access
6 Citations
4,229 Views
13 Pages

11 January 2022

Background: This study was a multicenter, randomized, double-blinded, placebo-controlled phase III clinical trial to investigate the efficacy and safety of an olmesartan/amlodipine single pill plus rosuvastatin combination treatment for patients with...

  • Article
  • Open Access
10 Citations
2,568 Views
17 Pages

Iron(III)–Quercetin Complexes’ Safety for MRI Cell Tracking in Cell Therapy Applications: Cytotoxic and Genotoxic Assessment

  • Nathupakorn Dechsupa,
  • Panida Kosintarajit,
  • Kanyapak Kamkan,
  • Thanyalak Khanjina,
  • Chonticha Sirikul,
  • Phattarawadee Innuan,
  • Authaphinya Suwan,
  • Nampeung Anukul and
  • Jiraporn Kantapan

13 August 2022

The theranostic agent iron–quercetin complex (IronQ) provides a T1-positive magnetic resonance imaging (MRI) contrast agent. The magnetically IronQ-labeled cells can be used for cell tracking and have active biological applications in promoting...

  • Article
  • Open Access
11 Citations
3,053 Views
13 Pages

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma

  • Irene Appolloni,
  • Francesco Alessandrini,
  • Laura Menotti,
  • Elisa Avitabile,
  • Daniela Marubbi,
  • Noemi Piga,
  • Davide Ceresa,
  • Francesca Piaggio,
  • Gabriella Campadelli-Fiume and
  • Paolo Malatesta

24 August 2021

Glioblastoma is a lethal primary brain tumor lacking effective therapy. The secluded onset site, combined with the infiltrative properties of this tumor, require novel targeted therapies. In this scenario, the use of oncolytic viruses retargeted to g...

  • Review
  • Open Access
2 Citations
14,356 Views
25 Pages

6 August 2021

Parts I and II of this three-part series indicated how a global review of both English-language and non-English language papers, plus a focus on a lipidosterolic extract of Serenoa repens (LSESr) having a standardized fatty acid profile, have togethe...

  • Article
  • Open Access
1 Citations
2,704 Views
14 Pages

The Safety and Immunogenicity of a 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT) in Infants: A Double-Blind, Randomized, Phase III Trial

  • Zhiqiang Xie,
  • Jiangjiao Li,
  • Xue Wang,
  • Lili Huang,
  • Jinbo Gou,
  • Wei Zhang,
  • Haitao Huang,
  • Wangyang You,
  • Feiyu Wang and
  • Xiaolong Li
  • + 4 authors

16 December 2024

Objectives: This study aimed to evaluate the immunogenicity and safety of a 13-valent pneumococcal polysaccharide conjugate vaccine (CRM197/TT) (PCV13i) in infants. Methods: A total of 1200 infants were randomly assigned to either the experimental PC...

  • Systematic Review
  • Open Access
38 Citations
14,511 Views
14 Pages

28 September 2021

Tirzepatide is a novel once-a-week dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, currently under trial to assess glycemic efficacy and safety in people with type 2 diabetes. A systematic review and me...

  • Conference Report
  • Open Access
1,462 Views
16 Pages

WHO Workshop Report: Regulatory Science to Inform Clinical Pathways for Shigella Vaccines Intended for Use in Children in Low- and Middle-Income Countries

  • Robert W. Kaminski,
  • Patricia B. Pavlinac,
  • James A. Platts-Mills,
  • Elizabeth T. Rogawski McQuade,
  • William P. Hausdorff,
  • Richard A. Isbrucker,
  • Kirsten S. Vannice,
  • Marco Cavaleri,
  • Sonali Kochhar and
  • Kirsty Mehring-LeDoare
  • + 5 authors

23 April 2025

Infectious diarrhea caused by Shigella remains a significant global health concern, and several vaccine candidates are approaching phase III clinical studies in the target population of young children in low- and middle-income countries. The World He...

  • Article
  • Open Access
738 Views
15 Pages

21 September 2025

Tetrahydrofuran (THF) and methanol (MeOH) are widely used as organic solvents in chemical, pharmaceutical, and other industrial fields. The wastewater from producing 1,4-butanediol contains THF, MeOH, and water ternary azeotropic mixture. In this stu...

  • Article
  • Open Access
15 Citations
4,647 Views
17 Pages

Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial

  • Mine Durusu Tanriover,
  • Ozlem Altuntas Aydin,
  • Rahmet Guner,
  • Orhan Yildiz,
  • Ilhami Celik,
  • Hamdi Levent Doganay,
  • Sukran Kose,
  • Sila Akhan,
  • Emin Halis Akalin and
  • Zafer Sezer
  • + 3 authors

4 November 2022

We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and...

  • Systematic Review
  • Open Access
12 Citations
5,484 Views
14 Pages

Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials

  • Laercio Lopes da Silva,
  • Pedro Nazareth Aguiar,
  • Robin Park,
  • Eduardo Edelman Saul,
  • Benjamin Haaland and
  • Gilberto de Lima Lopes

26 May 2021

Background: The use of checkpoint inhibitors has changed the treatment landscape for gastroesophageal cancer in the third-line setting. However, success rates in earlier treatment lines are highly variable across trials. Herein, we compare the effica...

  • Article
  • Open Access
3 Citations
3,995 Views
12 Pages

Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial

  • Zhao-Yan Song,
  • Moo-Hyun Kim,
  • Han-Cheol Lee,
  • Sung-Ji Park,
  • Moo-Yong Rhee,
  • Jong-Il Choi,
  • Sang-Hyun Kim,
  • In-Ho Chae,
  • Young-Joon Hong and
  • Nam-Ho Lee
  • + 5 authors

19 March 2023

Background: The introduction of a fixed-dose combination (FDC) is expected to improve treatment compliance. Methods: There were 181 subjects who were randomized to three groups: ezetimibe–rosuvastatin 10/20 mg + telmisartan 80 mg, ezetimibe&nda...

  • Article
  • Open Access
12 Citations
4,431 Views
15 Pages

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

  • Aleksandr V. Kudriavtsev,
  • Anna V. Vakhrusheva,
  • Nickolay A. Kryuchkov,
  • Maria E. Frolova,
  • Konstantin A. Blagodatskikh,
  • Taras V. Ivanishin,
  • Milana Djonovic,
  • Ekaterina A. Romanovskaya-Romanko,
  • Anton N. Kovalenko and
  • Dmitry A. Lioznov
  • + 6 authors

1 February 2023

COVID-19, being a life-threatening infection that evolves rapidly, remains a major public health concern calling for the development of vaccines with broad protection against different pathogenic strains and high immunogenicity. Aside from this, othe...

  • Article
  • Open Access
1 Citations
2,175 Views
15 Pages

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study

  • Yoshifumi Kadono,
  • Hiroyuki Konaka,
  • Takahiro Nohara,
  • Kouji Izumi,
  • Satoshi Anai,
  • Kiyohide Fujimoto,
  • Tomoyuki Koguchi,
  • Kei Ishibashi,
  • Noriyasu Kawai and
  • Keita Nakane
  • + 4 authors

13 May 2023

Background: The sequence of first-line cytokine and second-line molecular targeted therapies may be suitable for some patients with metastatic renal cell carcinoma (mRCC) because of the expectation of complete remission and durable response achieved...

  • Article
  • Open Access
6 Citations
2,913 Views
20 Pages

1 August 2023

Objective: In this paper, we aim to show that the immunogenicity of the lyophilized human rabies vaccine (Vero cells) (investigational vaccine) developed by Dalian Aleph Biomedical Co., Ltd. in healthy participants aged 10–60 years old is non-i...

  • Correction
  • Open Access
699 Views
2 Pages

1 August 2025

The authors would like to make the following corrections to this published paper [...]

  • Article
  • Open Access
5 Citations
4,042 Views
15 Pages

11 December 2021

Modern cell culture-based technology eliminates vaccine manufactures reliance on embryonated chicken eggs, which may become compromised during an avian influenza pandemic. Four studies (total N = 6230) assessed the immunogenicity and safety of mammal...

  • Article
  • Open Access
4 Citations
3,083 Views
11 Pages

Knowledge and Attitudes towards Patient Safety among Students in Physical Therapy in Spain: A Longitudinal Study

  • Joaquina Montilla-Herrador,
  • José A. Lozano-Meca,
  • Aitor Baño-Alcaraz,
  • Carmen Lillo-Navarro,
  • Rodrigo Martín-San Agustín and
  • Mariano Gacto-Sánchez

(1) Background: Patient safety is a discipline of health care management aiming to prevent and reduce errors and harm to patients. The assessment of knowledge and attitudes on patient safety among students in physical therapy is still scarce; no stud...

  • Article
  • Open Access
6 Citations
4,242 Views
14 Pages

Background: Nurses experience an alarming rate of violence in the workplace. While previous work has indicated that working conditions play an important role in workplace violence outcomes, these studies have not used comprehensive and systematically...

  • Article
  • Open Access
963 Views
17 Pages

Multi-Objective Optimization of Speed Profile for Railway Catenary Maintenance Vehicle Operations Based on Improved Non-Dominated Sorting Genetic Algorithm III

  • Bingli Zhang,
  • Gan Shen,
  • Yixin Wang,
  • Yangyang Zhang,
  • Chengbiao Zhang,
  • Xinyu Wang,
  • Zhongzheng Liu and
  • Xiang Luo

15 April 2025

Railway catenary maintenance vehicles are essential for ensuring the safety and efficiency of electrified railway systems. The implementation of pre-optimized speed profiles significantly reduces the energy consumption while improving key operational...

  • Brief Report
  • Open Access
12 Citations
6,371 Views
8 Pages

A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes

  • Claire McGee,
  • Ann Liebert,
  • Brian Bicknell,
  • Vincent Pang,
  • Vivian Isaac,
  • Craig S. McLachlan,
  • Hosen Kiat and
  • Geoffrey Herkes

13 April 2023

Emerging evidence is increasingly supporting the use of transcranial photobiomodulation (tPBM) to improve symptoms of neurodegenerative diseases, including Parkinson’s disease (PD). The objective of this study was to analyse the safety and effi...

  • Article
  • Open Access
1 Citations
1,524 Views
13 Pages

10 September 2024

Convenient, rapid, highly sensitive and on-site iron determination is important for environmental safety and human health. We developed a sensing system for the detection of Fe(III) in water based on 7-mercapto-4-methylcoumarine (MMC)-stabilized silv...

  • Review
  • Open Access
41 Citations
5,578 Views
20 Pages

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients

  • Giulia Radi,
  • Oriana Simonetti,
  • Giulio Rizzetto,
  • Federico Diotallevi,
  • Elisa Molinelli and
  • Annamaria Offidani

18 November 2021

Background: Atopic dermatitis (AD) is an inflammatory skin disease characterized by a wide phenotypic variety with a very complex pathophysiological mechanism that has led to the identification of new therapeutic targets, such as janus kinasis (JAK)...

of 24